LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 59.85 | 27.76 | 4387 | 6062 | 0.7236 | 0.9185 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 59.85 | 27.76 | 4174 | 6062 | 0.6885 | 0.9062 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 59.85 | 27.76 | 4326 | 6062 | 0.7136 | 0.9150 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 61.56 | 27.76 | 138 | 6217 | 0.0222 | 0.2280 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 61.56 | 27.76 | 4551 | 6217 | 0.7320 | 0.9217 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 61.56 | 27.76 | 4343 | 6217 | 0.6985 | 0.9102 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 61.56 | 27.76 | 4539 | 6217 | 0.7301 | 0.9210 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 63.26 | 27.76 | 150 | 6465 | 0.0232 | 0.2393 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 63.26 | 27.76 | 4693 | 6465 | 0.7258 | 0.9201 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 63.26 | 27.76 | 4566 | 6465 | 0.7062 | 0.9135 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 63.26 | 27.76 | 4736 | 6465 | 0.7325 | 0.9224 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 64.97 | 27.76 | 178 | 6656 | 0.0267 | 0.2650 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 64.97 | 27.76 | 4922 | 6656 | 0.7394 | 0.9251 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 64.97 | 27.76 | 4339 | 6656 | 0.6518 | 0.8946 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 64.97 | 27.76 | 4861 | 6656 | 0.7302 | 0.9220 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 66.67 | 27.76 | 193 | 6695 | 0.0288 | 0.2777 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 66.67 | 27.76 | 5056 | 6695 | 0.7551 | 0.9303 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 66.67 | 27.76 | 4555 | 6695 | 0.6803 | 0.9050 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 66.67 | 27.76 | 5028 | 6695 | 0.7509 | 0.9289 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 68.37 | 27.76 | 159 | 6879 | 0.0231 | 0.2454 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 68.37 | 27.76 | 5218 | 6879 | 0.7585 | 0.9317 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 68.37 | 27.76 | 4472 | 6879 | 0.6501 | 0.8946 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 68.37 | 27.76 | 5133 | 6879 | 0.7462 | 0.9277 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 70.08 | 27.76 | 200 | 6849 | 0.0292 | 0.2821 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 70.08 | 27.76 | 5426 | 6849 | 0.7922 | 0.9422 | MN20160318_Q01 | D14 |